Nevro to Present at Truist Securities MedTech Conference
Nevro to Present at Truist Securities MedTech Conference
REDWOOD CITY, Calif., June 11, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that members of its management team will participate in a "fireside chat" (question-and-answer) session at the Truist Securities MedTech Conference on Tuesday, June 18, 2024, beginning at approximately 8:40 am EDT.
全球醫療器械公司Nevro Corp. (紐交所:nevro)將於2024年6月18日星期二早上8:40參加Truist Securities MedTech大會的“爐邊談話”(問答)環節。
A live webcast of the session and a replay of the webcast will be available on the Events and Presentations page in the Investors section of the company's website at .
現場網絡直播和重播將在該公司網站投資者部分的活動和演示頁面上提供。
Internet Posting of Information
信息的互聯網發佈
Nevro routinely posts information that may be important to investors in the "Investor Relations" section of its website at . The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.
Nevro定期在其網站投資者關係部分發布可能對投資者重要的信息。該公司鼓勵投資者和潛在投資者經常查看Nevro網站以獲取重要信息。關於Nevro
About Nevro
Nevro總部位於加利福尼亞州Redwood City，是一家全球醫療器械公司，專注於提供全面、能夠改變生活的治療方案，爲慢性疼痛的治療開創了標準。該公司創立的最初宗旨是幫助更多患有疼痛的病人，並發展出了其專有的10 kHz療法，這是一種以證據爲基礎的非藥物創新，已經在全球影響了超過115000名患者的生活。Nevro全面的HFX脊髓神經刺激 (SCS)平台包括Senza SCS系統和支持慢性軀幹和肢體疼痛及痛性糖尿病神經病變的治療的支持服務。
Headquartered in Redwood City, California, Nevro is a global medical device company focused on delivering comprehensive, life-changing solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. The company started with a simple mission to help more patients suffering from debilitating pain and developed its proprietary 10 kHz Therapy, an evidence-based, non-pharmacologic innovation that has impacted the lives of more than 115,000 patients globally. Nevro's comprehensive HFX spinal cord stimulation (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy.
Nevro最近增加了治療慢性骶髂關節疼痛的微創治療選項，現在提供了SI關節融合空間中最全面的產品組合，旨在滿足醫生的偏好和不同的患者需求，以提高患者的治療效果和生活質量。
Nevro recently added a minimally invasive treatment option for patients suffering from chronic sacroiliac joint ("SI joint") pain and now provides the most comprehensive portfolio of products in the SI joint fusion space, designed to meet the preferences of physicians and varying patient needs in order to improve outcomes and quality of life for patients.
Senza、Senza II、Senza Omnia、和HFX iQ是唯一提供Nevro專有10kHz療法的SCS系統。Nevro獨特的支持服務爲每個病人提供HFX教練支持，以促進他們的止痛旅程，爲每個醫生提供HFX雲洞察以增強患者和實踐管理。
Senza, Senza II, Senza Omnia, and HFX iQ are the only SCS systems that deliver Nevro's proprietary 10 kHz Therapy. Nevro's unique support services provide every patient with HFX Coach support throughout their pain relief journey and every physician with HFX Cloud insights for enhanced patient and practice management.
SENZA、SENZA II、SENZA OMNIA、OMNIA、HF10、HF10標誌、10 kHz療法、HFX、HFX標誌、HFX iQ、HFX iQ標誌、HFX算法、HFX CONNECT、HFX Connect標誌、HFX ACCESS、HFX Access標誌、HFX COACH、HFX Coach標誌、HFX CLOUD、HFX Cloud標誌、RELIEF MULTIPLIED、X標誌、NEVRO、和NEVRO標誌是Nevro Corp.的商標或註冊商標。涵蓋Senza HFX iQ和其他Nevro產品的專利列在Nevro.com/patents想要了解更多有關Nevro的內容，請在Angie McCabe
SENZA, SENZA II, SENZA OMNIA, OMNIA, HF10, the HF10 logo, 10 kHz Therapy, HFX, the HFX logo, HFX iQ, the HFX iQ logo, HFX Algorithm, HFX CONNECT, the HFX Connect logo, HFX ACCESS, the HFX Access logo, HFX COACH, the HFX Coach logo, HFX CLOUD, the HFX Cloud logo, RELIEF MULTIPLIED, the X logo, NEVRO, and the NEVRO logo are trademarks or registered trademarks of Nevro Corp. Patents covering Senza HFX iQ and other Nevro products are listed at Nevro.com/patents.
副總裁，投資者關係&nevro.com/專利.
To learn more about Nevro, connect with us on LinkedIn, X, Facebook, and Instagram.
Nevro公司。LinkedIn, X, Facebook和Instagram.
Investors and Media:
Angie McCabe
Vice President, Investor Relations &
Corporate Communications
[email protected]
投資者和媒體:
安吉·麥凱比
投資者關係副總裁&
企業通訊
[email protected]
SOURCE Nevro Corp.
來源：Nevro公司。
譯文內容由第三人軟體翻譯。